Our assumption is based on the observation that point mutations generated within the NF1-LRD domain (D1849N and W1952*) abolished cell invasion of glioma cells lines and non-NF1-patient-derived glioma cells (Fig. 4). The gene discussed is NF1; the disease is glioma.